Dr at Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China
Liang Yang, MD, is a 33-year-old orthopedic surgeon at Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, China. Specializing in biomimetic materials for orthopedic reconstruction, he focuses on repairing bone defects under pathological conditions like osteoporosis. His innovative work on hydroxyapatite (HA) modification and chiral-engineered biomaterials has led to significant advancements in bone healing and regeneration.
Publication Profile
orcid
🎓 Education
Liang Yang earned his MD in Orthopedics from Shanghai Jiao Tong University School of Medicine. His academic pursuits have centered on advancing orthopedic materials, particularly through modifying HA to enhance bioactivity. Yang’s education combined intensive clinical training with cutting-edge research on bioactive ion doping (Sr2+/Fe3+) in HA for bone regeneration, culminating in impactful publications and novel biomaterial development. His studies positioned him at the forefront of orthopedic biomimetics.
💼 Experienc
Dr. Yang has dedicated his career to orthopedic surgery and biomaterial research at Shanghai Sixth People’s Hospital. His expertise spans developing bioactive hydroxyapatite materials, pioneering chiral-engineered biomaterials, and addressing osteoporosis-induced bone defects. Yang has led multiple research projects, resulting in publications in high-impact journals. His work reflects a seamless blend of surgical practice and translational research, bridging the gap between clinical needs and innovative material solutions.
🏆 Awards and Honors
Dr. Yang’s contributions to orthopedic biomaterials have earned him recognition in scientific and medical communities. His publications in journals like Advanced Science and Chem. Eng. J. have been widely cited. He received institutional awards for innovation in biomimetic material development and recognition from Shanghai Jiao Tong University for advancing orthopedic reconstruction techniques. His groundbreaking work on chiral hydroxyapatite further positioned him as a leader in biomaterial innovation.
🔬 Research Focus
Liang Yang’s research focuses on biomimetic materials for orthopedic reconstruction, particularly hydroxyapatite (HA) modification to enhance bioactivity and bone regeneration. His work explores doping HA with Sr2+/Fe3+ ions to modulate immunoregulation, angiogenesis, and osteogenesis. Recently, Yang synthesized chiral hydroxyapatite (CHA) with enantiomer-dependent osseointegration properties, unveiling L-CHA’s superior potential for osteoporosis treatment. His research paves the way for next-gen chiral-engineered biomaterials in orthopedics.
Publications 📖
Chirality‐Induced Hydroxyapatite for Osteoporotic Osseointegration – Advanced Science, 2024. DOI: 10.1002/advs.202411602.
Focus: Enantioselective bone-implant interactions to enhance osseointegration in osteoporosis.
Graphene Oxide Quantum Dot Scaffold – Advanced Functional Materials, 2023. DOI: 10.1002/ADFM.202211709.
Focus: Immuno-inductive angiogenesis and nerve regeneration via biocompatible nanoscaffolds.
Cryogenically 3D Printed Biomimetic Scaffolds – Chemical Engineering Journal, 2022. DOI: 10.1016/J.CEJ.2021.133459.
Focus: Bone tissue engineering using Sr2+/Fe3+ doped hydroxyapatite scaffolds.
Biomimetic Porous Scaffolds – Biomedical Materials, 2022. DOI: 10.1088/1748-605X/ac4b45.
Focus: Accelerated angiogenesis/osteogenesis with doped hydroxyapatite.
3D Printed Porous Scaffolds for Bone Tissue – Biofabrication, 2021. DOI: 10.1088/1758-5090/ABCF8D.
Focus: Bioactive scaffolds enhancing bone regeneration.
Anterior Acetabular Fracture Fixation – BMC Musculoskeletal Disorders, 2021. DOI: 10.1186/S12891-021-04034-W.
Focus: Surgical fixation methods for acetabular fractures.
Cartilage Changes with Glucocorticoids – Cartilage, 2021. DOI: 10.1177/1947603520978574.
Focus: Epiphyseal cartilage effects in glucocorticoid-treated mice.
🔹 Conclusion
Dr. Liang Yang’s pioneering work in chiral hydroxyapatite and bioactive bone materials makes him a strong contender for the Best Researcher Award. His contributions to orthopedic biomaterials, innovative solutions for bone defects, and significant publication record underscore his potential to drive transformative advancements in orthopedic surgery and bone regeneration.